| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/13/1997 | CA2231442A1 Therapeutic azide compounds |
| 03/13/1997 | CA2231114A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | CA2229036A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/12/1997 | EP0761668A2 Non-classical antifolates |
| 03/12/1997 | EP0761226A1 Method of potentiating antibiotics with polyphenols |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
| 03/12/1997 | EP0760818A1 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760815A1 Processes for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid |
| 03/12/1997 | EP0760814A1 A process for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid |
| 03/12/1997 | EP0760813A1 Inhibitors of farnesyl-protein transferase |
| 03/12/1997 | EP0760812A1 Pharmaceutical diketopiperazine compounds |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760672A1 Angiotensin ii for improving fertilization |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760658A1 Compounds for inhibiting osteoclast-mediated bone resorption |
| 03/12/1997 | EP0760657A1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 03/12/1997 | EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 03/12/1997 | EP0648207B1 Vitamin d analogues |
| 03/12/1997 | EP0644873B1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 03/12/1997 | EP0565587B1 THE EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE ON PROTEIN KINASE-C ACTIVITY; MELANOMA CELL GROWTH $i(IN VITRO); METASTATIC POTENTIAL $i(IN VIVO) AND HUMAN PLATELET AGGREGATION |
| 03/12/1997 | EP0561876B1 Use of angiotensin ii receptor antagonists in the treatment of atheroma |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |
| 03/12/1997 | CN1144656A Pharmaceutical compositions containing irbesartan |
| 03/11/1997 | US5610319 Compound useful as antiproliferative agents and GARFT inhibitors |
| 03/11/1997 | US5610308 Process for preparing intermediates for thrombin inhibitors |
| 03/11/1997 | US5610295 4-amino-2-(hetero)aryl-butanamides useful as 5-HT1A -antagonists |
| 03/11/1997 | US5610294 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 03/11/1997 | US5610195 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 03/11/1997 | US5610193 Pharmaceutical composition |
| 03/11/1997 | US5610192 Inhibitors of metazoan parasite proteases |
| 03/11/1997 | US5610178 Macrolides and the use thereof |
| 03/11/1997 | US5610172 Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals |
| 03/11/1997 | US5610169 Pharmaceutical Composition containing slightly water-soluble drug |
| 03/11/1997 | US5610168 Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 03/11/1997 | US5610166 Methods for inhibiting angiogenesis |
| 03/11/1997 | US5610154 Bicyclic carboxamides |
| 03/11/1997 | US5610153 Benzazepinone derivatives |
| 03/11/1997 | US5610150 Prostate cancer, enzyme inhibitors |
| 03/11/1997 | US5610146 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 03/11/1997 | US5610141 Cell division stimulant |
| 03/11/1997 | US5609590 PH-triggered osmotic bursting delivery devices |
| 03/11/1997 | EP0699442A4 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/11/1997 | CA2099263C Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/11/1997 | CA1338981C Biologically active proteins and a method for their production |
| 03/09/1997 | CA2184783A1 Nonclassical antifolates |
| 03/06/1997 | WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | WO1997008191A1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin |
| 03/06/1997 | WO1997008180A1 Method to improve the biological and antiviral activity of protease inhibitors |
| 03/06/1997 | WO1997008174A1 Interleukin converting enzyme and apoptosis |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/06/1997 | WO1997008155A1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 03/06/1997 | WO1997008145A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | WO1997008144A1 Substituted benzylaminopiperidine compounds |
| 03/06/1997 | WO1997008143A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | WO1997008133A1 Amide compounds and use of the same |
| 03/06/1997 | WO1997007805A1 Interleukin converting enzyme and apoptosis |
| 03/06/1997 | WO1997007804A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin |
| 03/06/1997 | WO1997007750A1 Administration of ketamine to manage pain and to reduce drug dependency |
| 03/06/1997 | WO1997007685A1 Capsules containing freeze-dried powdered green tea leaves |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | CA2502764A1 Amide compounds |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230487A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | CA2230209A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | CA2229141A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin |
| 03/05/1997 | EP0760365A2 Alkenyl-benzoylguanidines |
| 03/05/1997 | EP0760239A2 Therapeutic agents for use in cancer therapy |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759976A1 The isolation and production of catalytic antibodies using phage technology |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759918A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| 03/05/1997 | EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 03/05/1997 | EP0759783A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 03/05/1997 | EP0759781A1 Method for treating and preventing atherosclerosis |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0759760A1 Wound healing agent |
| 03/05/1997 | EP0759758A1 Sialic acid/fucose based medicaments |
| 03/05/1997 | EP0759757A1 Oral liquid alendronate formulations |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759751A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same |
| 03/05/1997 | EP0643069B1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 03/05/1997 | EP0591333B1 Azanorbornane derivatives |
| 03/05/1997 | CN1144528A Process for preparation of salt of clavulanic acid |
| 03/05/1997 | CN1144480A Guanylhydrazones for treating inflammatory conditions |
| 03/05/1997 | CN1034171C 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 03/04/1997 | US5608110 Heteroatom-bearing ligands and metal complexes thereof |
| 03/04/1997 | US5608095 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 03/04/1997 | US5608084 And vascular pathologies; multistep preparation by reacting a hydroquinone with alkyl vinyl ketone, esterifying hydroxy 3,4-dihydro-2h-1-benzopyran, demethylating ether, reacting with alkyl 5-bromopentanoate, hydrolyzing, two more steps |
| 03/04/1997 | US5608082 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 03/04/1997 | US5608079 Certain fused pyrrolecarboxanilides; a new class of GABA brain receptor ligands |
| 03/04/1997 | US5608060 Diagnosis and treatment of cancer; drug delivery to target cells |
| 03/04/1997 | US5608052 Enzyme inhibitors of beta-lactamase |
| 03/04/1997 | US5607999 Homo and copolymers with pigments |
| 03/04/1997 | US5607978 Prostaglandins for vision defects |